Oligonucleotide-based inhibitors are synthetic sequences of nucleotides that can interact with specific target molecules. These inhibitors can be designed to bind to mRNA, proteins, or even other nucleic acids, thereby modulating the activity of the target. Common types include antisense oligonucleotides and aptamers.